記住我
Volume 12, Issue 4, April 2024, Pages 1062-1064
Author links open overlay panelRobert M. Naclerio MD, FACS a, Daniel L. Hamilos MD, FAAAAI bShow moreReferences (13)There are more references available in the full text version of this article.
Conflicts of interest: R. M. Naclerio reports being on the advisory board for Sanofi and Lyra and being a speaker for Regeneron. D. L. Hamilos has no conflicts of interest to disclose.
View full text© 2024 American Academy of Allergy, Asthma & Immunology
Recommended articlesArticle Metrics
留言 (0)